| Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study T Kuehn, I Bauerfeind, T Fehm, B Fleige, M Hausschild, G Helms, ... The lancet oncology 14 (7), 609-618, 2013 | 1576 | 2013 |
| Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update M Kaufmann, GN Hortobagyi, A Goldhirsch, S Scholl, A Makris, ... Journal of Clinical Oncology 24 (12), 1940-1949, 2006 | 955 | 2006 |
| Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2–overexpressing breast … M Untch, PA Fasching, GE Konecny, S Hasmüller, A Lebeau, ... Journal of Clinical Oncology 29 (25), 3351-3357, 2011 | 611 | 2011 |
| Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer F Holst, PR Stahl, C Ruiz, O Hellwinkel, Z Jehan, M Wendland, A Lebeau, ... Nature genetics 39 (5), 655-660, 2007 | 489 | 2007 |
| HER-2/neu Analysis in Archival Tissue Samples of Human Breast Cancer: Comparison of Immunohistochemistry and Fluorescence In Situ Hybridization A Lebeau, D Deimling, C Kaltz, A Sendelhofert, A Iff, B Luthardt, M Untch, ... Journal of Clinical Oncology 19 (2), 354-363, 2001 | 445 | 2001 |
| Current perspectives on HER2 testing: a review of national testing guidelines M Bilous, M Dowsett, W Hanna, J Isola, A Lebeau, A Moreno, ... Modern pathology 16 (2), 173-182, 2003 | 360 | 2003 |
| Monitoring Primary Systemic Therapy of Large and Locally Advanced Breast Cancer by Using Sequential Positron Emission Tomography Imaging With [18F … J Schwarz-Dose, M Untch, R Tiling, S Sassen, S Mahner, S Kahlert, ... Journal of Clinical Oncology 27 (4), 535-541, 2009 | 267 | 2009 |
| Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines HJ Schünemann, D Lerda, C Quinn, M Follmann, P Alonso-Coello, ... Annals of internal medicine 172 (1), 46-56, 2020 | 240 | 2020 |
| Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism S Bahram, S Gilfillan, LC Kühn, R Moret, JB Schulze, A Lebeau, ... Proceedings of the National Academy of Sciences 96 (23), 13312-13317, 1999 | 211 | 1999 |
| PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed … M Untch, PA Fasching, GE Konecny, F von Koch, U Conrad, W Fett, ... Annals of oncology 22 (9), 1988-1998, 2011 | 198 | 2011 |
| Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer M Untch, V Möbus, W Kuhn, BR Muck, C Thomssen, I Bauerfeind, ... Journal of Clinical Oncology 27 (18), 2938-2945, 2009 | 188 | 2009 |
| Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature A Lebeau, E Zeindl-Eberhart, EC Müller, J Müller-Höcker, ... Blood, The Journal of the American Society of Hematology 100 (5), 1817-1827, 2002 | 177 | 2002 |
| Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017)–Part … A Wöckel, J Festl, T Stüber, K Brust, M Krockenberger, PU Heuschmann, ... Geburtshilfe und Frauenheilkunde 78 (11), 1056-1088, 2018 | 144 | 2018 |
| EGFR, HER-2/neu, Cyclin D1, p21 and p53 in Correlation to Cell Proliferation and Steroid Hormone Receptor Status in Ductal Carcinoma in situ of the Breast A Lebeau, A Unholzer, G Amann, M Kronawitter, I Bauerfeind, ... Breast cancer research and treatment 79, 187-198, 2003 | 124 | 2003 |
| Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): results of a European consensus meeting SH Heywang-Köbrunner, R Sinnatamby, A Lebeau, A Lebrecht, ... European journal of radiology 72 (2), 289-294, 2009 | 121 | 2009 |
| ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer P Tarantino, G Viale, MF Press, X Hu, F Penault-Llorca, A Bardia, ... Annals of Oncology 34 (8), 645-659, 2023 | 107 | 2023 |
| Multigene assays for classification, prognosis, and prediction in breast cancer: a critical review on the background and clinical utility P Sinn, S Aulmann, R Wirtz, S Schott, F Marmé, Z Varga, A Lebeau, ... Geburtshilfe und Frauenheilkunde 73 (09), 932-940, 2013 | 97 | 2013 |
| Gene amplification in ductal carcinoma in situ of the breast L Burkhardt, TJ Grob, I Hermann, E Burandt, M Choschzick, F Jänicke, ... Breast cancer research and treatment 123, 757-765, 2010 | 95 | 2010 |
| Tissue Distriburtion of Major Matrix Metalloproteinases and their Transcripts in Human Breast Carcinomas A Lebeau, AG Nerlich, U Sauer, R Lichtinghagen, U Lohrs Anticancer research 19 (5), 4257-4264, 1999 | 80 | 1999 |
| Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer TJ Grob, U Heilenkötter, S Geist, P Paluchowski, C Wilke, F Jaenicke, ... Breast cancer research and treatment 134, 561-567, 2012 | 77 | 2012 |
